Achilles治疗 将其癌症免疫治疗技术卖给了AstraZeneca 1200万美元。 Achilles Therapeutics sold its cancer immunotherapy tech to AstraZeneca for $12 million.

Achilles治疗技术公司以1 200万美元将技术资产出售给AstraZeneca。 Achilles Therapeutics has sold its technology assets to AstraZeneca for $12 million. 这项交易涉及转让Achilles的专利技术,这些技术旨在识别和发展个性化癌症免疫疗法。 This deal involves the transfer of Achilles' proprietary technologies, which are designed to identify and develop personalized cancer immunotherapies. 销售标志着生物医学技术部门的一项重大举措,反映了制药公司之间正在进行的合并和战略调整。 The sale marks a significant move in the biomedical technology sector, reflecting the ongoing consolidation and strategic realignments among pharmaceutical companies.